NOX1 deficiency protects from aortic dissection in response to angiotensin II

Gaetan Gavazzi1, Christine Deffert, Candice Trocme

  • 1Department of Geriatrics, University Hospital of Grenoble, Grenoble, France.

Insights

Reduced nicotinamide-adenine dinucleotide phosphate oxidase (NOX1) deficiency protects against angiotensin II-induced aortic dissection in mice. This protection is linked to NOX1-dependent suppression of tissue inhibitor of metalloproteinase 1.

Area of Science:

  • Vascular Biology
  • Oxidative Stress Biology
  • Cardiovascular Research

Background:

  • Oxidative stress contributes to vascular damage and the development of aortic dissection and aneurysms.
  • The role of specific oxidative stress enzymes, like NOX1, in aortic dissection pathogenesis requires further elucidation.

Purpose of the Study:

  • To investigate the role of the superoxide-generating enzyme NOX1 in angiotensin II-induced aortic dissection.
  • To explore the underlying molecular mechanisms, including gene expression and protease/inhibitor balance, in NOX1-deficient mice.

Main Methods:

  • Utilized a mouse model of angiotensin II-induced hypertension to study aortic dissection.
  • Compared the incidence of aortic dissection in wild-type and NOX1-deficient mice.
  • Analyzed gene expression and protein levels of key regulators, such as tissue inhibitor of metalloproteinase 1.

Main Results:

  • NOX1-deficient mice showed significantly reduced incidence of aortic dissection compared to wild-type mice when treated with angiotensin II (4% vs. 23%).
  • Hypertension induced by norepinephrine did not cause aortic dissection in either wild-type or NOX1-deficient mice, indicating hypertension alone is insufficient.
  • NOX1 deficiency led to increased expression of tissue inhibitor of metalloproteinase 1 at both mRNA and protein levels in the aorta.

Conclusions:

  • NOX1 plays a critical role in the pathogenesis of angiotensin II-dependent aortic dissection.
  • NOX1-mediated suppression of tissue inhibitor of metalloproteinase 1 is a key mechanism contributing to vascular damage and aortic dissection.
  • Targeting NOX1 or restoring tissue inhibitor of metalloproteinase 1 may offer therapeutic strategies for preventing aortic dissection.

Related Concept Videos

Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...